The NHLBI Office of Translational Alliances and Coordination (OTAC) helps to accelerate the translation of new discoveries into innovative biomedical products to prevent, diagnose, and treat heart, lung, and blood disorders. OTAC coordinates the NHLBI Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs, as well as two translational research initiatives directed at advancing new technologies from the university to the marketplace: the NIH Centers for Accelerated Innovations (NCAI) and the NIH Research Evaluation and Commercialization Hubs (REACH) programs.
In addition, OTAC serves as a central point-of-contact for information about the NHLBI’s small business funding opportunities; facilitates alliances between the federal and private sector stakeholders; and offers resources and advisory services to support biomedical innovators.
Not sure about how to contact the FDA? Wondering about how to protect your intellectual property? Need advice on your commercialization plan? OTAC has brought together a team of experts skilled in regulatory affairs, intellectual property, and business development. Learn more about our Product Development Support Services.
If you are trying to reach a specific team member, mention them in the Subject line:
- NHLBI Small Business Program: Mike Pieck
- NIH Centers for Accelerated Innovations: Kathleen Rousche
- NIH Research Evaluation and Commercialization Hubs: Kathleen Rousche
- Regulatory Affairs: Chris Sasiela
- Business Development: Gary Robinson
- Entrepreneurs-in-Residence: Luis Gutierrez and Steve Wolpe (REACH)
For questions or to schedule a time to speak with our staff members, please use the NHLBI Small Biz Inquiry Form. Please indicate on the Inquiry Form whether you are contacting us about a new or existing application, award, or other type of support resources, and then choose the primary reason for your inquiry. For slide requests from a recent NHLBI OTAC presentation, choose Resources Inquiry and Educational Resources.
Learn from our community of experts who have created a series of webinars explaining the basics of entrepreneurship and biomedical technology development. Topic areas include regulatory, business development, intellectual property, and insurance payment. Please check out the full playlist of NHLBI Small Biz Hangouts on YouTube.
Catalyze will help investigators transform their scientific discoveries into products, such as medical devices, diagnostics, and therapeutics, that address unmet medical needs. View funding information for the NHLBI Catalyze program.
The Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs are two of the largest sources of early-stage capital for U.S. small business, acting as engines of innovation for developing and commercializing novel technologies and products to promote the prevention, diagnosis, and treatment of heart, lung, blood, and sleep disorders. The NHLBI provides grant and contract funding opportunities and resources to support small businesses performing research and development on technologies related to the mission of the NHLBI.
NIH Centers for Accelerated Innovations (NCAI) & Research Evaluation and Commercialization Hubs (REACH)
The NIH Centers for Accelerated Innovations and Research Evaluation and Commercialization Hubs programs accelerate the translation of scientific discovery into products that improve health for patients. With these two programs, the NIH has created a nationwide network of six Centers and Hubs to develop best practices for translating academic innovations into new drugs, devices, and diagnostics.